Impact of Monoclonal Antibody Treatment on Post-Acute COVID-19 Syndrome
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
- Status
- COMPLETED
- Phase
- PHASE4
COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
- Status
- TERMINATED
- Phase
- PHASE2
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
- Status
- RECRUITING
- Phase
- PHASE2
Dupilumab in the Treatment of Keloids
- Status
- COMPLETED
- Phase
- PHASE4
Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Examine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
- Status
- TERMINATED
- Phase
- PHASE2
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
ASP8374 + Cemiplimab in Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use of Dupilumab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A